Hyundai Bioscience Co Ltd
KOSDAQ:048410
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hyundai Bioscience Co Ltd
Free Cash Flow
Hyundai Bioscience Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
Free Cash Flow
-₩37.2B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-52%
|
|
|
AmorePacific Corp
KRX:090430
|
Free Cash Flow
₩499.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Amorepacific Group
KRX:002790
|
Free Cash Flow
₩522.7B
|
CAGR 3-Years
183%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Cosmax Inc
KRX:192820
|
Free Cash Flow
-₩100.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-7%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Free Cash Flow
₩351.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Free Cash Flow
₩111.7B
|
CAGR 3-Years
50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
28%
|
|
Hyundai Bioscience Co Ltd
Glance View
HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.
See Also
What is Hyundai Bioscience Co Ltd's Free Cash Flow?
Free Cash Flow
-37.2B
KRW
Based on the financial report for Dec 31, 2025, Hyundai Bioscience Co Ltd's Free Cash Flow amounts to -37.2B KRW.
What is Hyundai Bioscience Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-52%
The average annual Free Cash Flow growth rates for Hyundai Bioscience Co Ltd have been -27% over the past three years , -16% over the past five years , and -52% over the past ten years .
